Your browser is no longer supported. Please, upgrade your browser.
Settings
ADMA ADMA Biologics, Inc. daily Stock Chart
ADMA [NASD]
ADMA Biologics, Inc.
Index- P/E- EPS (ttm)-1.89 Insider Own0.50% Shs Outstand42.48M Perf Week6.14%
Market Cap198.38M Forward P/E- EPS next Y-0.31 Insider Trans274.96% Shs Float33.40M Perf Month-2.51%
Income-55.00M PEG- EPS next Q-0.33 Inst Own43.30% Short Float4.56% Perf Quarter-10.19%
Sales24.20M P/S8.20 EPS this Y-19.00% Inst Trans16.12% Short Ratio6.57 Perf Half Y26.56%
Book/sh0.51 P/B9.16 EPS next Y46.80% ROA-61.70% Target Price9.13 Perf Year41.52%
Cash/sh- P/C- EPS next 5Y- ROE-211.60% 52W Range2.01 - 5.70 Perf YTD45.48%
Dividend- P/FCF- EPS past 5Y-6.60% ROI-48.60% 52W High-18.06% Beta1.80
Dividend %- Quick Ratio3.60 Sales past 5Y82.70% Gross Margin-64.60% 52W Low132.34% ATR0.30
Employees295 Current Ratio4.90 Sales Q/Q53.80% Oper. Margin- RSI (14)48.51 Volatility5.69% 5.97%
OptionableYes Debt/Eq0.00 EPS Q/Q22.50% Profit Margin- Rel Volume2.02 Prev Close4.53
ShortableYes LT Debt/Eq1.88 EarningsAug 13 AMC Payout- Avg Volume231.81K Price4.67
Recom1.80 SMA20-0.14% SMA50-4.69% SMA20018.82% Volume463,765 Change3.09%
Dec-11-17Reiterated Maxim Group Buy $13 → $8
Nov-14-17Upgrade Raymond James Mkt Perform → Outperform
Jan-23-17Upgrade Maxim Group Hold → Buy $13
Aug-01-16Downgrade Maxim Group Buy → Hold
Jul-25-16Reiterated Maxim Group Buy $24 → $14
May-13-15Reiterated Maxim Group Buy $18 → $24
Dec-08-14Initiated Oppenheimer Outperform $20
Dec-01-14Reiterated Maxim Group Buy $16 → $18
Jun-25-18 07:08AM  ADMA Biologics Added to the Russell 3000 and Russell 2000 Indexes GlobeNewswire
Jun-13-18 07:48AM  Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111 Benzinga
Jun-12-18 04:05PM  ADMA Biologics Announces Closing of $40M Public Offering GlobeNewswire
Jun-08-18 09:08AM  ADMA Biologics Announces Pricing of Public Offering of Common Stock GlobeNewswire
Jun-07-18 04:05PM  ADMA Biologics Announces Proposed Public Offering of Common Stock GlobeNewswire
Jun-04-18 10:00AM  ADMA: Biotest Share Retirement Good for Shareholders Zacks Small Cap Research -7.98%
May-18-18 09:47AM  Who Owns Most Of ADMA Biologics Inc (NASDAQ:ADMA)? Simply Wall St.
07:30AM  Blog Exposure - ADMA Biologics Received US Patent for Treating Respiratory Infections ACCESSWIRE
May-16-18 07:30AM  ADMA Biologics Granted U.S. Patent for Treating Respiratory Infections GlobeNewswire
May-14-18 05:28PM  Adma Biologics: 1Q Earnings Snapshot Associated Press +5.41%
05:05PM  ADMA Biologics Reports First Quarter 2018 Financial Results GlobeNewswire
01:17PM  ADMA Biologics Retires Approximately 8.6 Million Shares Previously Issued to Biotest GlobeNewswire
May-08-18 01:55PM  Will ADMA Biologics Incs (NASDAQ:ADMA) Earnings Grow In The Next Couple Of Years? Simply Wall St.
Apr-24-18 07:28AM  ADMA Biologics Announces the Release of its First Commercial Batch of Nabi-HB Manufactured Under its Ownership GlobeNewswire
Mar-19-18 06:30PM  ADMA Biologics Inc (NASDAQ:ADMA): Should The Recent Earnings Drop Worry You? Simply Wall St. +5.75%
Mar-12-18 03:50PM  When Will ADMA Biologics Inc (NASDAQ:ADMA) Turn A Profit? Simply Wall St.
Mar-05-18 07:00AM  ADMA Biologics Reports Full Year 2017 Financial Results GlobeNewswire
Feb-27-18 07:08AM  ADMA Biologics to Present at Raymond James 39th Annual Institutional Investors Conference GlobeNewswire
Jan-29-18 04:32PM  Does ADMA Biologics Incs (NASDAQ:ADMA) CEO Salary Compared Well With Others? Simply Wall St.
Dec-15-17 10:55AM  Does ADMA Biologics Incs (NASDAQ:ADMA) Past Performance Indicate A Weaker Future? Simply Wall St. +6.05%
Dec-13-17 07:50AM  Wired News ADMA Files Biologics License Application for Its Third Plasma Collection Center ACCESSWIRE
Dec-11-17 07:08AM  ADMA Files Biologics License Application For Its Third Plasma Collection Center GlobeNewswire -5.43%
Nov-29-17 10:46AM  ETFs with exposure to ADMA Biologics, Inc. : November 29, 2017 Capital Cube
Nov-27-17 10:10AM  ADMA Biologics Inc (ADMA): What Does It Mean For Your Portfolio? Simply Wall St.
Nov-15-17 08:08AM  ADMA Biologics Further Enhances Intellectual Property Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Compositions GlobeNewswire +11.27%
Nov-13-17 05:00PM  ADMA: Third Quarter 2017 Financial Results and Corporate Update Zacks Small Cap Research +6.90%
12:30PM  ADMA Biologics Announces Closing of $42M Follow-On Offering GlobeNewswire
Nov-10-17 03:35PM  Are ADMA Biologics Incs (ADMA) Interest Costs Too High? Simply Wall St.
Nov-09-17 08:58AM  ADMA Biologics Announces Pricing of Follow-On Offering GlobeNewswire +11.11%
Nov-08-17 02:29PM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 8, 2017 Capital Cube
Nov-07-17 09:34AM  ETFs with exposure to ADMA Biologics, Inc. : November 7, 2017 Capital Cube +8.74%
Nov-03-17 05:08PM  Adma Biologics posts 3Q profit Associated Press
05:02PM  ADMA Biologics Provides Corporate Update and Reports Third Quarter 2017 Financial Results GlobeNewswire
Oct-27-17 04:11PM  Why ADMA Biologics Inc (ADMA) Could Be A Buy Simply Wall St.
Oct-25-17 09:45AM  ETFs with exposure to ADMA Biologics, Inc. : October 25, 2017 Capital Cube
Oct-11-17 07:11AM  Marathon Asset Management and ADMA Biologics Complete $30 Million Debt Refinancing GlobeNewswire
Sep-28-17 10:08AM  ETFs with exposure to ADMA Biologics, Inc. : September 28, 2017 Capital Cube -10.70%
Sep-07-17 12:03PM  ETFs with exposure to ADMA Biologics, Inc. : September 7, 2017 Capital Cube
Sep-05-17 11:53AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017 Capital Cube
Aug-28-17 09:00AM  ADMA: Second Quarter 2017 Financial Results and Corporate Update Zacks Small Cap Research
Aug-23-17 07:38AM  ADMA Biologics to Present at Upcoming Investor Conferences GlobeNewswire
Aug-11-17 09:25PM  Adma Biologics reports 2Q loss Associated Press
04:15PM  ADMA Biologics Provides Corporate Update and Reports Second Quarter 2017 Financial Results GlobeNewswire
Jul-31-17 04:15PM  ADMA Biologics Strengthens Patent Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Methods GlobeNewswire
Jul-13-17 03:23PM  ETFs with exposure to ADMA Biologics, Inc. : July 13, 2017 Capital Cube
Jun-27-17 07:08AM  ADMA Biologics Provides Corporate Timeline and Activities Update to Stockholders GlobeNewswire +12.78%
Jun-06-17 03:33PM  ADMA Biologics Completes Acquisition of Biotests Therapy Business Unit Assets GlobeNewswire
Jun-05-17 01:59PM  ETFs with exposure to ADMA Biologics, Inc. : June 5, 2017 Capital Cube
Jun-02-17 10:28AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
May-30-17 07:38AM  ADMA Biologics Stockholders Vote to Approve Acquisition of Certain Assets from Biotest Pharmaceuticals Corporation GlobeNewswire
May-25-17 04:15PM  ADMA Biologics to Present at Jefferies 2017 Healthcare Conference GlobeNewswire
May-19-17 03:00PM  ADMA: 1Q:17 Results and Biotest Acquisition: Valuation Implications Zacks Small Cap Research
May-12-17 04:08PM  Adma Biologics reports 1Q loss Associated Press
04:05PM  ADMA Biologics Provides Corporate Update and Reports First Quarter 2017 Financial Results GlobeNewswire
Apr-20-17 02:10PM  ETFs with exposure to ADMA Biologics, Inc. : April 20, 2017 Capital Cube
Apr-07-17 03:41PM  ETFs with exposure to ADMA Biologics, Inc. : April 7, 2017 Capital Cube
Mar-27-17 05:39PM  Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of ADMA Biologics, Inc. - ADMA PR Newswire
Mar-20-17 09:26AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube
09:26AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
Mar-14-17 03:01PM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Capital Cube
03:01PM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
Mar-02-17 01:04PM  ADMA BIOLOGICS, INC. Financials
Feb-24-17 04:37PM  ADMA Biologics Reports Year End 2016 Financial Results, Accomplishments and Upcoming Milestones GlobeNewswire
04:32PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
Feb-17-17 04:32PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jan-23-17 04:59PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu +7.91%
03:24PM  ADMA Biologics upgraded by Maxim Group
07:00AM  ADMA Biologics to Acquire Certain Assets from Biotest Pharmaceuticals Corporation and Become a Vertically Integrated Commercial Plasma Products Company GlobeNewswire
Dec-15-16 01:43AM  ADMA Biologics Inc (ADMA): Does It Stack Up To Its Peers? Insider Monkey
01:43AM  ADMA Biologics Inc (ADMA): Does It Stack Up To Its Peers? at Insider Monkey
Nov-21-16 10:15AM  ADMA: Incremental Progress on CMC Issue Resolution. Zacks Small Cap Research
Nov-16-16 12:32PM  ETFs with exposure to ADMA Biologics, Inc. : November 16, 2016
Nov-14-16 11:34AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
Nov-10-16 06:32PM  Adma Biologics reports 3Q loss
04:33PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:30PM  ADMA Biologics Reports Third Quarter 2016 Results GlobeNewswire
Oct-07-16 04:39PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial S
Sep-21-16 10:12AM  ETFs with exposure to ADMA Biologics, Inc. : September 21, 2016 Capital Cube
10:12AM  ETFs with exposure to ADMA Biologics, Inc. : September 21, 2016
Sep-09-16 04:56PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Sep-01-16 07:38AM  ADMA Biologics to Present at Upcoming Investor Conferences GlobeNewswire
Aug-17-16 12:15PM  ADMA - Reviewing 2Q:16 Results; Waiting for Clarity on Resubmission Timeline Zacks Small Cap Research -5.78%
Aug-16-16 10:45AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 Capital Cube
10:45AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016
Aug-12-16 04:47PM  Adma Biologics reports 2Q loss +6.39%
04:46PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:38PM  ADMA Biologics Reports Second Quarter 2016 Results GlobeNewswire
Aug-04-16 05:07PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Aug-02-16 11:00AM  ADMA CRL Isolated to Partner Manufacturing Issues: Anticipate 8 Month Delay
Aug-01-16 06:56PM  INVESTOR NOTICE: Goldberg Law PC Announces an Investigation of Claims against ADMA Biologics, Inc. and Advises Investors with Losses to Contact the Firm Business Wire -17.32%
05:26PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding Possible Violations of Federal Securities Laws by Certain Officers and Directors of ADMA Biologics, Inc. Business Wire
03:31PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ADMA Biologics, Inc. (ADMA) PR Newswire
02:47PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA PR Newswire
12:57PM  ADMA Biologics Inc (ADMA) Just Gave Us A CRL Opportunity at Insider Monkey
10:02AM  ADMA Biologics tanks 21% as Raymond James downgrades stock at MarketWatch
Jul-29-16 07:14PM  ADMA Biologics Receives Complete Response Letter from FDA for Pending Biologics License Application GlobeNewswire +7.39%
Jul-20-16 12:05PM  ETFs with exposure to ADMA Biologics, Inc. : July 20, 2016
Jun-16-16 07:38AM  ADMA Biologics to Present at the 2016 JMP Securities Life Sciences Conference GlobeNewswire
Jun-10-16 05:02PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote o
Jun-01-16 02:35PM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical trial for the treatment of primary immune deficiency disease. The company also operates source plasma collection facilities in Norcross and Marietta, Georgia. In Addition, the company offers Nabi-HB, for the treatment of acute exposure; and Bivigam, for the treatment of primary humoral immunodeficiency. It distributes its products through independent distributors, sales agents, specialty pharmacies, and others. The ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grossman Adam SPresident and CEOJun 08Buy4.7852,301249,999796,301Jun 11 07:09 AM
Grossman Adam SPresident and CEOJun 08Buy4.7820,921100,00232,527Jun 11 07:09 AM
Grossman Jerrold BDirectorJun 08Buy4.7831,381150,00131,381Jun 11 07:10 AM
Grossman Jerrold BDirectorJun 08Buy4.7820,921100,00298,007Jun 11 07:10 AM
LENZ BRIANVP, CFOJun 08Buy4.785,00023,90020,000Jun 11 07:08 AM
Guiheen Lawrence P.DirectorJun 08Buy4.7820,00095,60025,000Jun 11 07:09 AM
RICHMAN ERIC IDirectorJun 08Buy4.785,23024,99936,530Jun 11 07:08 AM
Biotest AGDirectorNov 09Buy2.155,813,95412,500,00110,109,534Nov 13 01:54 PM
RICHMAN ERIC IDirectorNov 09Buy2.1525,00053,75031,300Nov 13 01:51 PM
LENZ BRIANVP, CFONov 09Buy2.156,50013,97515,000Nov 13 01:49 PM
Grossman Adam SPresident and CEONov 09Buy2.15485,0001,042,750744,000Nov 13 01:46 PM
Mond JamesEVP, CSO and CMONov 09Buy2.1510,00021,50013,389Nov 13 01:45 PM